Lung Cancer

The addition of sintilimab to chemotherapy prolonged PFS for patients with pretreated EGFR-mutated nonsquamous non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

The FDA expanded the approval of atezolizumab to include adjuvant treatment of certain patients with non-small cell lung cancer.

In an interview with Healio, Pasi A. Jänne, MD, PhD, discussed a study on the use of an antibody-drug conjugate in some patients with non-small cell lung cancer.

Matthew A. Steliga, MD, discusses a presentation from World Conference on Lung Cancer which focused on the importance of integrating tobacco cessation strategies into lung cancer practice in a video interview with Healio

In this video, Matthew A. Steliga, MD, discusses cessation program engagement data that was presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Matthew A. Steliga, MD, spoke with Healio about a presentation on smoking cessation programs for patients being screened for lung cancer given at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this video, Matthew A. Steliga, MD, highlights presentations in tobacco cessation given at this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this video, Andrew Ciupek, PhD, spoke with Healio about “the great wealth of information being presented” at this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this video, Andrew Ciupek, PhD, highlights presentations given during the patient advocacy track at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Among patients with COPD in South Korea, with an intermediate tuberculosis burden, history of pulmonary TB was associated with an increased risk for developing lung cancer, researchers reported.